Childhood immature teratoma of ovary

Summary

Childhood immature teratoma of ovary (MONDO:0004082) is a disease. A subtype of childhood teratoma of the ovary — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	childhood immature teratoma of ovary
Mondo ID	MONDO:0004082
DOID	DOID:7037
NCIT	C6547
UMLS	C1332990
MedGen	232353
GARD	0023809
Is cancer (heuristic)	no

Also known as: childhood immature ovarian teratoma · childhood immature teratoma of the ovary · childhood ovarian immature teratoma · immature ovarian teratoma of childhood · paediatric immature ovarian teratoma · paediatric immature teratoma of ovary · paediatric immature teratoma of the ovary · paediatric ovarian immature teratoma · pediatric immature ovarian teratoma · pediatric immature teratoma of ovary · pediatric immature teratoma of the ovary · pediatric ovarian immature teratoma

Disease family

This is a subtype of childhood teratoma of the ovary. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › germ cell tumor › childhood germ cell tumor › pediatric ovarian germ cell tumor › childhood teratoma of the ovary › childhood immature teratoma of ovary

Related subtypes (1): childhood mature teratoma of the ovary

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.